Patent details
EP3860599 Title: (+)-ALPHA-DIHYDROTETRABENAZINE DOSAGE REGIMEN FOR TREATING MOVEMENT DISORDERS
Basic Information
- Publication number:
- EP3860599
- PCT Application Number:
- EP2019076800
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP197871676
- PCT Publication Number:
- WO2020070236
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- (+)-ALPHA-DIHYDROTETRABENAZINE DOSAGE REGIMEN FOR TREATING MOVEMENT DISORDERS
- French Title of Invention:
- RÉGIME POSOLOGIQUE DE (+)-ALPHA-DIHYDROTÉTRABÉNAZINE DESTINÉ AU TRAITEMENT DE TROUBLES DU MOUVEMENT
- German Title of Invention:
- (+)-ALPHA-DIHYDROTETRABENAZIN-DOSIERUNGSSCHEMA ZUR BEHANDLUNG VON BEWEGUNGSSTÖRUNGEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 16/05/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 28/05/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 15/05/2024
- Unitary Effect Registration Date:
- 28/05/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 03/10/2019
- Grant date:
- 15/05/2024
- EP Publication Date:
- 11/08/2021
- PCT Publication Date:
- 09/04/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 15/05/2024
- EP B1 Publication Date:
- 15/05/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 03/10/2039
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 08/05/2024
- Name:
- Adeptio Pharmaceuticals Limited
- Address:
- Suite 1 3rd Floor 11-12 St. James's Square, London SW1Y 4LB, United Kingdom (GB)
Inventor
1
- Name:
- DUFFIELD, Andrew John
- Address:
- United Kingdom (GB)
2
- Name:
- PANDYA, Anant
- Address:
- United Kingdom (GB)
Priority
- Priority Number:
- 201816192
- Priority Date:
- 04/10/2018
- Priority Country:
- United Kingdom (GB)
Classification
- IPC classification:
- A61K 31/4375; A61P 21/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202420
- Publication date:
- 15/05/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202425
- Publication date:
- 19/06/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202426
- Publication date:
- 26/06/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|